Shilpa Biologicals commissions ADC GMP manufacturing facility in Dharwad
The company informed that the facility which is fully operational, is designed to meet global regulatory approval standards
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Shilpa Medicare
Shilpa Medicare enters strategic partnership with NXI Therapeutics AG
Shilpa Medicare, a global integrated pharmaceutical and CDMO company, announced the signing of a long-term development and…
Practical techno-commercial aspects of ‘Womb to Tomb’ product lifecycle
Dr Jayant Karajgi, COO, Shilpa Medicare, outlined a strategic approach to pharma product development from ideation and execution,…
Shilpa Medicare receives CDSCO SEC Nod for IND Nor UDCA tablets for NAFLD treatment
Shilpa Medicare secures Subject Expert Committee approval for its novel therapy Nor Ursodeoxycholic Acid, following positive phase…
Shilpa Biologicals partners with mAbTree Biologics for novel immuno-oncology asset
Shilpa to undertake both development and commercial supply for mAbTree’s novel checkpoint inhibitor
Shilpa Medicare partners with Dr Reddy’s for Sputnik V vaccine production
The companies are also exploring the option to manufacture Sputnik Light, a single-dose version of the vaccine in the near future
Shilpa Medicare gets US FDA tentative nod for Apremilast Tablets
The tablets are used in the treatment of 'psoriatic arthritis'
Shilpa Medicare gets Import Alert from USFDA
Three products have been exempted from the Import Alert - Azacitidine for Injection, Cyclophosphamide Capsules and Erlotinib…
US FDA issues warning letter to Shilpa Medicare for Jadcherla facility, Telangana
The company believes that the warning letter will have minimum impact of disruption of supplies and the existing revenues from…
Shilpa Medicare forays into the OTC segment
Launches Green T Film, a ready-to-drink product